Another BsAb, Glypican-3 (GPC3)/CD3 BITE, is thought to recruit cytotoxic T lymphocyte (CTL) to eliminate GPC3 + HCC cells (46). The gene discussed is GPC3; the disease is hepatocellular carcinoma.